Tert-butyl(5r)-3,3-difluoro-5-hydroxy-piperidine-1-carboxylate, 98%, 5g

4-Methyl-1,8-naphthyridin-2-ol, 95.0%, 250mg

(R)-2-Aminopropanamide, 95.0%, 25g

Ethyl 5,6,7,8-tetrahydro-1,7-naphthyridine-3-carboxylate hydrochloride, 95.0%, 100mg

4-bromo-5-(2-thienyl)-1H-pyrazole, 95.0%, 5g

3-Bromo-2-trifluoromethylthiophene, 95.0%, 250mg

3-(2-Aminothiazol-4-yl)benzoic acid, 95.0%, 250mg

2,6-Difluoro-3-methylacetophenone, 97.0%, 25g

GC capillary column ROTI®Cap-5, 60 m, 0.25 mm, 0.50 µm, 1 Piece(s)

4-Azidobenzoic acid, 95.0%, 5g

6-Bromo-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile, 98%, 5g

6-Bromo-3-methoxy-1-phenyl-1H-indazole, 95%, 250mg

Ethyl 3-Methylcrotonate>97.0%(GC)25mL